Battlefield Company SpotitEarly Trained Dogs And AI To Sniff Out Common Cancers
Developing early cancer detection tools could be the key to saving millions of lives. Now, one innovative startup is taking a fresh approach that blends biotechnology, artificial intelligence, and man’s best friend. Battlefield company SpotitEarly trained dogs and AI to sniff out common cancers, creating a unique, non-invasive way to screen for multiple cancer types from the comfort of home.
Image Credits:SpotitEarly
A New Frontier In Early Cancer Detection
While multi-cancer early detection (MCED) tests are still being researched and have yet to receive FDA approval, some are already available for consumers willing to pay out of pocket. Tests like Grail’s Galleri blood test or whole-body MRIs from Prenuvo and Ezra can cost thousands of dollars. SpotitEarly, however, aims to make cancer screening more accessible, faster, and surprisingly intuitive — through the power of scent.
How SpotitEarly’s Dog-And-AI Combo Works
SpotitEarly has developed an at-home cancer test that analyzes human breath. The process combines trained dogs’ extraordinary sense of smell with an AI system that interprets their reactions to identify potential cancer markers.
According to SpotitEarly CEO Shlomi Madar, the idea is backed by science. “Dogs can be trained to sniff out diseases — especially cancer — in humans,” he told TechCrunch. Many people have even shared stories of their dogs sensing something was wrong long before a diagnosis was made.
From Military Training To Medical Breakthrough
Madar, who brings 15 years of experience in health and biotech, founded the company with three partners — including a former K9 unit commander. Their goal: to build a reliable, scalable cancer screening method that could revolutionize early detection.
Users can easily participate by collecting a simple breath sample at home and mailing it to SpotitEarly’s lab. There, 18 highly trained beagles analyze the sample. When a dog detects cancer-related particles, it signals by sitting — and the AI platform then confirms the result.
Why This Could Change Cancer Screening Forever
SpotitEarly’s method offers several advantages over traditional testing: it’s non-invasive, more affordable, and potentially scalable for large populations. By combining biological intuition with machine precision, the company is bridging the gap between nature and technology in healthcare.
If successful, SpotitEarly could pave the way for a future where early cancer detection is as easy — and as routine — as taking a breath.
Post a Comment